| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040780434 |
| P356 | DOI | 10.1038/GT.2008.26 |
| P698 | PubMed publication ID | 18323790 |
| P5875 | ResearchGate publication ID | 5528136 |
| P50 | author | Rob C Hoeben | Q47504188 |
| P2093 | author name string | R A Willemsen | |
| S K van den Hengel | |||
| S J Cramer | |||
| D Koppers-Lalic | |||
| J de Vrij | |||
| J Vellinga | |||
| T G Uil | |||
| E J H J Wiertz | |||
| M C Verweij | |||
| P2860 | cites work | The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction | Q24291966 |
| A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma | Q24319940 | ||
| Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
| The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol | Q29618773 | ||
| Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments | Q30478392 | ||
| A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes | Q30700012 | ||
| Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. | Q33181048 | ||
| Genetic engineering of T cell specificity for immunotherapy of cancer | Q33185580 | ||
| An oncolytic adenovirus redirected with a tumor-specific T-cell receptor | Q33308470 | ||
| The selection of intracellular antibodies. | Q33586057 | ||
| Simian virus 40 infection via MHC class I molecules and caveolae | Q33683308 | ||
| Identification of sites in adenovirus hexon for foreign peptide incorporation | Q33737591 | ||
| Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization | Q33844598 | ||
| Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. | Q34342665 | ||
| Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. | Q35019399 | ||
| Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX. | Q35140014 | ||
| Transductional targeting of adenovirus vectors for gene therapy | Q35609035 | ||
| The adenovirus capsid: major progress in minor proteins | Q36138215 | ||
| Molecular composition of the adenovirus type 2 virion | Q36852843 | ||
| Promoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes | Q36862082 | ||
| MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines | Q40066322 | ||
| Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid. | Q40176311 | ||
| Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu. | Q40245726 | ||
| A system for efficient generation of adenovirus protein IX-producing helper cell lines | Q40351305 | ||
| Fluorescently labeled adenovirus with pIX-EGFP for vector detection | Q40528180 | ||
| Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor | Q40541884 | ||
| Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX | Q40579221 | ||
| Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma | Q40634758 | ||
| Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation. | Q40643508 | ||
| Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev. | Q40884415 | ||
| The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability | Q41056729 | ||
| Targeted gene delivery by tropism-modified adenoviral vectors | Q41152060 | ||
| Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. | Q41237683 | ||
| CryoEM structure at 9A resolution of an adenovirus vector targeted to hematopoietic cells | Q41627278 | ||
| A quasi-atomic model of human adenovirus type 5 capsid | Q41627325 | ||
| Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells | Q42616240 | ||
| Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes | Q42831738 | ||
| Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences | Q44491759 | ||
| Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP. | Q44848779 | ||
| Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability | Q45731708 | ||
| Ligand recognition by alpha beta T cell receptors | Q46222293 | ||
| Lentivirus Vectors Encoding Both Central Polypurine Tract and Posttranscriptional Regulatory Element Provide Enhanced Transduction and Transgene Expression | Q61727540 | ||
| P433 | issue | 13 | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 978-989 | |
| P577 | publication date | 2008-03-06 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX | |
| P478 | volume | 15 |
| Q39455900 | A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction. |
| Q36544244 | A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth. |
| Q34571474 | Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures |
| Q37806749 | Capsid-Incorporation of Antigens into Adenovirus Capsid Proteins for a Vaccine Approach |
| Q34643252 | Chapter two--Adenovirus strategies for tissue-specific targeting |
| Q39624050 | Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors. |
| Q28742934 | Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging |
| Q34120709 | Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. |
| Q37227135 | Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody |
| Q59354245 | Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX |
| Q39561803 | Truncating the i-leader open reading frame enhances release of human adenovirus type 5 in glioma cells |
| Q39463819 | Use of Cre/loxP recombination to swap cell binding motifs on the adenoviral capsid protein IX. |
Search more.